These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4083634)

  • 1. [Immunotherapy of recent-onset type I diabetes mellitus].
    Assan R
    Ann Med Interne (Paris); 1985; 136(6):451-2. PubMed ID: 4083634
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunointervention in type 1 diabetes mellitus].
    Vialettes B
    Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 1 diabetes immunotherapy: is the glass half empty or half full?
    Herold KC; Bluestone JA
    Sci Transl Med; 2011 Aug; 3(95):95fs1. PubMed ID: 21832236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy in type 1 (insulin-dependent) diabetes].
    Galluzzo A
    Recenti Prog Med; 1984 Oct; 75(10):936-43. PubMed ID: 6083588
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of insulin-dependent diabetes.
    Bell DS; Acton RT
    Ala J Med Sci; 1985 Jul; 22(3):311-4. PubMed ID: 4025722
    [No Abstract]   [Full Text] [Related]  

  • 6. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding immuno-therapies for type 1 diabetes.
    Diabetes Obes Metab; 2000 Apr; 2(2):118. PubMed ID: 11220525
    [No Abstract]   [Full Text] [Related]  

  • 8. New prospects for immunotherapy at diagnosis of type 1 diabetes.
    Pozzilli P; Leslie RD
    Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.
    Lernmark Å; Larsson HE
    J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820
    [No Abstract]   [Full Text] [Related]  

  • 10. Outlook for immune intervention in type I diabetes.
    Grob PJ
    Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
    [No Abstract]   [Full Text] [Related]  

  • 11. Early intervention in insulin-dependent diabetes mellitus.
    Cahill GF
    Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
    [No Abstract]   [Full Text] [Related]  

  • 12. [Etiology and pathogenesis of type I diabetes].
    Ziegler AG
    Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
    Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
    Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenetics and new therapies in type I diabetes mellitus].
    Gannage-Yared MH
    J Med Liban; 1999; 47(2):139-43. PubMed ID: 10410471
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunotherapy of insulin-dependent diabetes mellitus].
    Satoh J; Seino H; Shintani S; Toyota T
    Nihon Rinsho; 1991 Feb; 49 Suppl():519-24. PubMed ID: 2033845
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.
    Waldron-Lynch F; Herold KC
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):303-17, viii. PubMed ID: 19328413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy--is the treatment worse than the disease?
    Soeldner JS
    West J Med; 1987 Mar; 146(3):356-7. PubMed ID: 3577124
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy for the prevention and treatment of type 1 diabetes.
    Goudy KS; Tisch R
    Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.